Recorded on September 6, 2018.
CB Therapeutics has developed natural cannabinoids in yeast, using just sugar. Our patent-pending process eliminates the need for any plants, reduces the production cycle to just 5 days and reduces the production cost by many fold for each type of cannabinoid molecule. We have acquired a pilot production plant in California for scaling up and manufacturing in the coming months.
Startup Battlefield Competition – CB Therapeutics | Disrupt SF 2018
From the collection TechCrunch Disrupt
May 27
Athens, Greece
StrictlyVC Athens is up next. Hear unfiltered insights straight from Europe’s tech leaders and connect with the people shaping what’s ahead. Lock in your spot before it’s gone.
